Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectors

Human Gene Therapy

Volumn 10, Issue 6, 1999, Pages 935-945

  Douglas, Janet ^a,b   Kelly, Patrick ^a   Evans, Jay T ^a,c   Garcia, J Victor ^a,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b SyStemics Inc   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GREEN FLUORESCENT PROTEIN; ZIDOVUDINE;

ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; ERYTHROID CELL; EXPRESSION VECTOR; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE; MARKER GENE; MOLONEY MURINE SARCOMA ONCOVIRUS; NONHUMAN; TRANSGENE;

ANTIGENS, CD34; CELL LINE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; LEUKEMIA VIRUS, MURINE; LUMINESCENT PROTEINS; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 0033541513     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018337     Document Type: Article

References (34)

1. AKKINA, R.K., WALTON, R.M., CHEN, M.L., LI, Q.X., PLANELLES, V., and CHEN, I.S. (1996). High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 70, 2581-2585.
2. ALLAY, J.A., PEARSONS, D.A., GALIPEAU, J., RIBERDY, J.M., ASHMUN, R.A., BLAKLEY, R.L., and SORRENTINO, B.P. (1998). In vivo selection of retrovirally transduced hematopoietic stem cells. Nature Med. 4, 1136-1143.
3. BHATIA, M., BONNET, D., KAPP, U., WANG, J.C., MURDOCH, B., and DICK, J.E. (1997). Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J. Exp. Med. 186, 619-624.
4. BLAESE, R.M. (1993). Development of gene therapy for immunodeficiency: Adenosine deaminase deficiency. Pediatr. Res. 33, S49-S53.
5. BLOMER, U., NALDINI, L., KAFRI, T., TRONO, D., VERMA, I.M., and GAGE, F.H. (1997). Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71, 6641-6649.
6. BONINI, C., FERRARI, G., VERZELETTI, S., SERVIDA, P., ZAPPONE, E., RUGGIERI, L., PONZONI, M., ROSSINI, S., MAVILIO, F., TRAVERSARI, C., and BORDIGNON, C. (1997). HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276, 1719-1724.
7. BURNS, J.C., FRIEDMANN, T., DRIEVER, W., BURRASCANO, M., and YEE, J.K. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. U.S.A. 90, 8033-8037. [See comments]
8. FAUCI, A.S. (1988). The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science 239, 617-622.
9. FAUCI, A.S. (1996). Host factors and the pathogenesis of HIV-induced disease. Nature (London) 384, 529-534.
10. HERSHFIELD, M.S., CHAFFEE, S., and SORENSEN, R.U. (1993). Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: Overview and case reports of three patients, including two now receiving gene therapy. Pediatr. Res. 33, S42-S47.
11. KALEKO, M., GARCIA, J.V., and MILLER, A.D. (1991). Persistent gene expression after retroviral gene transfer into liver cells in vivo. Hum. Gene Ther. 2, 27-32.
12. KIMPTON, J., and EMERMAN, M. (1992). Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66, 2232-2239.
13. LAROCHELLE, A., VORMOOR, J., HANENBERG, H., WANG, J.C., BHATIA, M., LAPIDOT, T., MORITZ, T., MURDOCH, B., XIAO, X.L., KATO, I., WILLIAMS, D.A., and DICK, J.E. (1996). Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nature Med. 2, 1329-1337.
14. LEARY, A.G., ZENG, H.Q., CLARK, S.C., and OGAWA, M. (1992). Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors. Proc. Natl. Acad. Sci. U.S.A. 89, 4013-4017.
15. LEWIS, P., HENSEL, M., and EMERMAN, M. (1992). Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11, 3053-3058.
16. + hematopoietic stem/progenitor cells from human umbilical cord blood. J. Exp. Med. 178, 2089-2096.
17. LU, L., XIAO, M., SHEN, R.N., GRIGSBY, S., and BROXMEYER, H.E. (1993b). Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 81, 41-48.
18. LUO, T., DOUGLAS, J.L., LIVINGSTON, R.L., and GARCIA, J.V. (1998). Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: Implications for HIV-based gene transfer systems. Virology 241, 224-233.
19. MCCUNE, J.M., NAMIKAWA, R., KANESHIMA, H., SHULTZ, L.D., LIEBERMAN, M., and WEISSMAN, I.L. (1988). The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241, 1632-1639.
20. MILLER, D.G., ADAM, M.A., and MILLER, A.D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242.
21. NALDINI, L., BLOMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
22. NOLTA, J.A., SMOGORZEWSKA, E.M., and KOHN, D.B. (1995). Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 86, 101-110.
23. NOLTA, J.A., DAO, M.A., WELLS, S., SMOGORZEWSKA, E.M., and KOHN, D.B. (1996). Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 93, 2414-2419.
24. PAROLIN, C., TADDEO, B., PALU, G., and SODROSKI, J. (1996). Use of cis-and trans-acting viral regulatory sequences to improve expression of human immunodeficiency virus vectors in human lymphocytes. Virology 222, 415-422.
25. PEDEN, K., EMERMAN, M., and MONTAGNIER, L. (1991). Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HTV-1ELI. Virology 185, 661-672.
26. PERSONS, D.A., MEHAFFEY, M.G., KALEKO, M., NIENHUIS, A.W., and VANIN, E.F. (1998). An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene. Blood Cells Mol. Dis. 24, 167-182.
27. SHIMADA, T., FUJII, H., MITSUYA, H., and NIENHUIS, A.W. (1991). Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector. J. Clin. Invest. 88, 1043-1047.
28. SNOECK, H.W., LARDON, F., LENJOU, M., NYS, G., VAN BOCKSTAELE, D.R., and PEETERMANS, M.E. (1993). Differential regulation of the expression of CD38 and human leukocyte antigen-DR on CD34+ hematopoietic progenitor cells by interleukin-4 and interferon-gamma. Exp. Hematol. 21, 1480-1486.
29. SPINA, C.A., GUATELLI, J.C., and RICHMAN, D.D. (1995). Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. J. Virol. 69, 2977-2988.
30. UCHIDA, N., SUTTON, R.E., FRIERA, A.M., HE, D., REITSMA, M.J., CHANG, W.C., VERES, G., SCOLLAY, R., and WEISSMAN, I.L. (1998). HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 95, 11939-11944.
31. VON SCHWEDLER, U., KORNBLUTH, R.S., and TRONO, D. (1994). The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 91, 6992-6996.
32. WEINBERG, J.B., MATTHEWS, T.J., CULLEN, B.R., and MALIM, M.H. (1991). Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J. Exp. Med. 174, 1477-1482.
33. WOFFENDIN, C., YANG, Z.Y., UDAYKUMAR, Xu.L., YANG, N.S., SHEEHY, M.J., and NABEL, G.J. (1994). Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells. Proc. Natl. Acad. Sci. U.S.A. 91, 11581-11585.
34. ZUFFEREY, R., NAGY, D., MANDEL, R.J., NALDINI, L., and TRONO, D. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotechnol. 15, 871-875.